Medicare Enrolled

Dr. David Burday, MD

Urology Physician · Tallahassee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2000 CENTRE POINTE BLVD, Tallahassee, FL 32308
8503090400
In practice since 2006 (19 years)
NPI: 1679594402 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burday from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burday? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burday

Dr. David Burday is an urology physician in Tallahassee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Burday performed 6,587 Medicare services across 2,351 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burday received a total of $5,821 from 43 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burday is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 18% volume in FL$ $5,821 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,587
Medicare services
Top 18% in FL for urology physician
2,351
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~347 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)3,400$0$1
Automated urinalysis949$2$5
Office visit, established patient (30-39 min)743$90$320
Office visit, established patient (20-29 min)276$63$227
Bladder ultrasound after voiding167$8$26
Blood draw (venipuncture)151$6$6
New patient office visit (45-59 min)138$118$424
Chronic care management, first 20 min/month129$50$159
Leuprolide acetate (for depot suspension), 7.5 mg126$132$336
X-ray of abdomen, 1 view82$22$60
Diagnostic exam of bladder and urethra using an endoscope67$61$207
Drug injection, under skin or into muscle47$10$35
Simple insertion of temporary bladder tube37$47$156
Injection, garamycin, gentamicin, up to 80 mg35$2$3
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle34$25$81
Ct scan of abdomen and pelvis without contrast30$74$208
Urinalysis, manual28$3$6
Ct scan of abdomen and pelvis before and after contrast24$180$518
Imaging of urinary tract following injection of a contrast agent20$19$52
Electronic assessment of bladder emptying17$3$22
Biopsy of prostate gland17$90$333
Ultrasound scan of pelvic region through rectum17$23$65
Ultrasonic guidance for needle placement17$22$63
Urinalysis with microscopic exam13$3$7
Simple bladder irrigation and/or instillation12$60$193
Ct scan of abdomen before and after contrast11$136$429
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,821
Total received (2018-2024)
Avg $832/year across 7 years
Top 37% in FL for urology physician
43
Companies
275
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,819 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$941
2023
$896
2022
$722
2021
$448
2020
$503
2019
$1,364
2018
$947

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$899
PFIZER INC.
$749
Axonics, Inc.
$601
Amgen Inc.
$324
Allergan, Inc.
$317
ABBVIE INC.
$304
Janssen Biotech, Inc.
$249
Allergan Inc.
$224
Endo Pharmaceuticals Inc.
$164
Ferring Pharmaceuticals Inc.
$164
NeoTract Inc.
$144
AbbVie Inc.
$142
Dendreon Pharmaceuticals LLC
$137
MEDIVATION FIELD SOLUTIONS LLC
$129
AbbVie, Inc.
$103
Boston Scientific Corporation
$99
Verity Pharmaceuticals Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$86
UroGen Pharma, Inc.
$75
Cook Medical LLC
$75
Medtronic, Inc.
$69
Myriad Genetic Laboratories, Inc.
$62
Antares Pharma, Inc.
$59
Bayer Healthcare Pharmaceuticals Inc.
$48
KARL STORZ Endoscopy-America
$47
Coloplast Corp
$46
Tempus AI, Inc
$41
LSI SOLUTIONS INC
$40
TOLMAR Pharmaceuticals, Inc.
$38
BOSTON SCIENTIFIC CORPORATION
$33
Sumitomo Pharma America, Inc.
$28
Rochester Medical Corporation
$28
Blue Earth Diagnostics Limited
$28
Tolmar, Inc.
$27
Olympus America Inc.
$25
IMMUNITYBIO, INC.
$25
Novartis Pharmaceuticals Corporation
$23
AstraZeneca Pharmaceuticals LP
$18
DAVOL INC.
$17
UROVANT SCIENCES INC
$15
Laborie Medical Technologies Corp.
$14
Myovant Sciences Inc.
$13
Retrophin, Inc.
$1
Top 3 companies account for 38.6% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 700 · ANKTIVA · ARISTA AH · ASCERTA · AVEED · Androgel · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · COOK · COOK MEDICAL LASERS · Cook · ELIGARD · ERLEADA · Eclipse · Erleada · FIRMAGON · Flex-X / IMAGE 1 S · GEMTESA · GENERAL THERAPIES · INTERSTIM · JELMYTO · JNW URTRAC · LUPRON DEPOT · LYNPARZA · LYNX · LithoVue · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PLUVICTO · PREMARIN · PROLARIS · PROVENGE · Porges Coloplast · Prolia · RESONANCE · SPACEOAR · SUTENT · TITAN · TOVIAZ · Trelstar · UroLift · VIAGRA · Veozah · XGEVA · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xofigo · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $88 per 100 Medicare services performed
Looking for a urology physician in Tallahassee?
Compare urology physicians in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
20
Per 100K population
6.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Burday is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Burday experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Burday performed 3,400 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burday receive payments from pharmaceutical companies?
Yes. Dr. Burday received a total of $5,821 from 43 companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burday's costs compare to other urology physicians in Tallahassee?
Dr. Burday's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burday) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →